Pharmacokinetics clinical trials

Explore recruiting pharmacokinetics clinical trials.

Recruiting pharmacokinetics studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pharmacokinetics trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Tablets (A. Menarini Industrie Farmaceutiche Riunite s.r.l.)

Romania

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

SEZanne: A Phase 2 Randomized, Open label, Multicenter Study to Evaluate the Optimal Dose, Safety, and Efficacy of ABBV-706 in Combination with Atezolizumab versus Standard of Care as First-Line Treatment in Subjects with Previously Untreated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Spain, Germany, Italy, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter, open-label, randomized study with single-arm extension period to assess the pharmacokinetics, safety and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension

Portugal, Hungary, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

(15681) Open-label, individual dose titration study to evaluate safety, tolerability and pharmacokinetics of riociguat in children from 6 to less than 18 years of age with pulmonary arterial hypertension (PAH)

Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

STS-001: An explorative clinical study to assess the potential of intravenously administered sodium thiosulfate in subjects with primary Raynaud’s phenomenon

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less than 12 Years Old with Hereditary Angioedema [Donidalorsen Treatment in Children with Hereditary Angioedema]

Italy, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacokinetics trials by city

Pharmacokinetics in Toronto Pharmacokinetics in Vancouver Pharmacokinetics in Montreal Pharmacokinetics in Calgary Pharmacokinetics in Edmonton Pharmacokinetics in Ottawa Pharmacokinetics in Winnipeg Pharmacokinetics in Quebec City Pharmacokinetics in Hamilton Pharmacokinetics in Kitchener Pharmacokinetics in London Pharmacokinetics in Halifax Pharmacokinetics in New York Pharmacokinetics in Los Angeles Pharmacokinetics in Chicago Pharmacokinetics in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease